(Q51632768)

8 April 2018

title

Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentration. (English)

1 reference

8 April 2018

1 reference

1 reference

T Shiba

1

1 reference

8 April 2018

H Kajinuma

2

1 reference

8 April 2018

K Suzuki

3

1 reference

8 April 2018

R Hagura

4

1 reference

8 April 2018

A Kawai

5

1 reference

8 April 2018

H Katagiri

6

1 reference

8 April 2018

H Sando

7

1 reference

8 April 2018

W Shirakawa

8

1 reference

8 April 2018

K Kosaka

9

1 reference

8 April 2018

N Kuzuya

10

1 reference

8 April 2018

publication date

1 September 1986

1 reference

8 April 2018

Diabetes Research and Clinical Practice

published in

1 reference

8 April 2018

volume

2

1 reference

8 April 2018

issue

5

1 reference

8 April 2018

page(s)

301-306

1 reference

8 April 2018

Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Behaviour of glibenclamide on repeated administration to diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Radioimmunoassay of glipizide in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Drug compliance in diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Drug compliance in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Determination of a new hypoglycemic drug, gliclazide, in human serum by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Radioimmunoassay of Glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

The metabolic fate of tolbutamide in man and in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2886%2980007-9

7 January 2021

10.1016/S0168-8227(86)80007-9

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018